HYTN Innovations Inc (TSE:HYTN) has released an update.
HYTN Innovations Inc., a Canadian leader in psychoactive and psychotropic product manufacturing, has achieved a significant milestone by obtaining GMP certification from Australia’s TGA for its Kelowna production facility. This certification, effective March 15th, 2024, allows the company to expand its manufacturing capabilities and engage in broader international trade, particularly in Australia’s robust medical cannabis market and the newly emerging German market. The company anticipates this will lead to substantial growth and new global partnerships in the burgeoning medical cannabis industry.
For further insights into TSE:HYTN stock, check out TipRanks’ Stock Analysis page.
